title: Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning.
authors.affiliation: Department of Neurology, San Raffaele Hospital, Milan, Italy vittorio.martinelli@hsr.it.
authors.forename: Vittorio
authors.initials: V
authors.lastname: Martinelli
authors.affiliation: Department of Neurology, San Raffaele Hospital, Milan, Italy.
authors.forename: Bruno
authors.initials: B
authors.lastname: Colombo
authors.affiliation: Department of Neurology, San Raffaele Hospital, Milan, Italy.
authors.forename: Gloria
authors.initials: G
authors.lastname: Dalla Costa
authors.affiliation: Department of Neurology, San Raffaele Hospital, Milan, Italy.
authors.forename: Dacia
authors.initials: D
authors.lastname: Dalla Libera
authors.affiliation: Department of Neurology, San Raffaele Hospital, Milan, Italy.
authors.forename: Lucia
authors.initials: L
authors.lastname: Moiola
authors.affiliation: Department of Neuroradiology, San Raffaele Hospital, Milan, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: Falini
authors.affiliation: Department of Neurology, San Raffaele Hospital, Milan, Italy.
authors.forename: Giancarlo
authors.initials: G
authors.lastname: Comi
authors.affiliation: Neuroimaging Research Unit, San Raffaele Scientific Institute, Milan, Italy.
authors.forename: Massimo
authors.initials: M
authors.lastname: Filippi
mesh_terms: D000293:Adolescent; D001921:Brain / Q000473:pathology*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab / Q000627:therapeutic use*; D011247:Pregnancy; D012008:Recurrence; D016896:Treatment Outcome
chemical_list: D000069442:Natalizumab